Global Transcriptomics Market Research Report 2024

Publication ID:

PB501246676

Publication Date:

January 16, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Transcriptomic incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics. The global transcriptomic market could see a whole lot of instances of new product launch. For example, Trio RNA-Seq launched by NuGEN Technologies, Inc. is particularly suited for low abundance transcripts applications as it offers an extremely sensitive whole transcriptomic solution. This innovation embodies three powerful technologies, viz. single primer isothermal amplification (SPIA), DimerFree, and AnyDeplete, for performing high sensitivity ribonucleic acid (RNA) analysis.
The global Transcriptomics market was valued at US$ 3775.2 million in 2023 and is anticipated to reach US$ 7413.6 million by 2030, witnessing a CAGR of 10.0% during the forecast period 2024-2030.
North America is the largest consumption place, with a consumption market share nearly 55% . Following North America, Europe is the second largest consumption place with the consumption market share of 25% .The key manufacturers are Thermo Fisher Scientific, Illumina, QIAGEN (Exiqon), Agilent Technologies, Roche, GE Healthcare, Bio-Rad Laboratories, Fluidigm etc. Top 3 companies occupied about 41% market share.
This report aims to provide a comprehensive presentation of the global market for Transcriptomics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transcriptomics.
Report Scope
The Transcriptomics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Transcriptomics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transcriptomics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm
Segment by Type
PCR
Microarray
Sequencing
Segment by Application
Pharmaceutical and Biotechnology
Academic Research and Government Institutes
Hospitals and Diagnostic Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transcriptomics companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transcriptomics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 PCR
1.2.3 Microarray
1.2.4 Sequencing
1.3 Market by Application
1.3.1 Global Transcriptomics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical and Biotechnology
1.3.3 Academic Research and Government Institutes
1.3.4 Hospitals and Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Transcriptomics Market Perspective (2019-2030)
2.2 Transcriptomics Growth Trends by Region
2.2.1 Global Transcriptomics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Transcriptomics Historic Market Size by Region (2019-2024)
2.2.3 Transcriptomics Forecasted Market Size by Region (2025-2030)
2.3 Transcriptomics Market Dynamics
2.3.1 Transcriptomics Industry Trends
2.3.2 Transcriptomics Market Drivers
2.3.3 Transcriptomics Market Challenges
2.3.4 Transcriptomics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transcriptomics Players by Revenue
3.1.1 Global Top Transcriptomics Players by Revenue (2019-2024)
3.1.2 Global Transcriptomics Revenue Market Share by Players (2019-2024)
3.2 Global Transcriptomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Transcriptomics Revenue
3.4 Global Transcriptomics Market Concentration Ratio
3.4.1 Global Transcriptomics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transcriptomics Revenue in 2023
3.5 Transcriptomics Key Players Head office and Area Served
3.6 Key Players Transcriptomics Product Solution and Service
3.7 Date of Enter into Transcriptomics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Transcriptomics Breakdown Data by Type
4.1 Global Transcriptomics Historic Market Size by Type (2019-2024)
4.2 Global Transcriptomics Forecasted Market Size by Type (2025-2030)
5 Transcriptomics Breakdown Data by Application
5.1 Global Transcriptomics Historic Market Size by Application (2019-2024)
5.2 Global Transcriptomics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Transcriptomics Market Size (2019-2030)
6.2 North America Transcriptomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Transcriptomics Market Size by Country (2019-2024)
6.4 North America Transcriptomics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Transcriptomics Market Size (2019-2030)
7.2 Europe Transcriptomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Transcriptomics Market Size by Country (2019-2024)
7.4 Europe Transcriptomics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Transcriptomics Market Size (2019-2030)
8.2 Asia-Pacific Transcriptomics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Transcriptomics Market Size by Region (2019-2024)
8.4 Asia-Pacific Transcriptomics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Transcriptomics Market Size (2019-2030)
9.2 Latin America Transcriptomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Transcriptomics Market Size by Country (2019-2024)
9.4 Latin America Transcriptomics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transcriptomics Market Size (2019-2030)
10.2 Middle East & Africa Transcriptomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Transcriptomics Market Size by Country (2019-2024)
10.4 Middle East & Africa Transcriptomics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Transcriptomics Introduction
11.1.4 Thermo Fisher Scientific Revenue in Transcriptomics Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Illumina
11.2.1 Illumina Company Detail
11.2.2 Illumina Business Overview
11.2.3 Illumina Transcriptomics Introduction
11.2.4 Illumina Revenue in Transcriptomics Business (2019-2024)
11.2.5 Illumina Recent Development
11.3 QIAGEN (Exiqon)
11.3.1 QIAGEN (Exiqon) Company Detail
11.3.2 QIAGEN (Exiqon) Business Overview
11.3.3 QIAGEN (Exiqon) Transcriptomics Introduction
11.3.4 QIAGEN (Exiqon) Revenue in Transcriptomics Business (2019-2024)
11.3.5 QIAGEN (Exiqon) Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Detail
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Transcriptomics Introduction
11.4.4 Agilent Technologies Revenue in Transcriptomics Business (2019-2024)
11.4.5 Agilent Technologies Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Transcriptomics Introduction
11.5.4 Roche Revenue in Transcriptomics Business (2019-2024)
11.5.5 Roche Recent Development
11.6 GE Healthcare
11.6.1 GE Healthcare Company Detail
11.6.2 GE Healthcare Business Overview
11.6.3 GE Healthcare Transcriptomics Introduction
11.6.4 GE Healthcare Revenue in Transcriptomics Business (2019-2024)
11.6.5 GE Healthcare Recent Development
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Detail
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories Transcriptomics Introduction
11.7.4 Bio-Rad Laboratories Revenue in Transcriptomics Business (2019-2024)
11.7.5 Bio-Rad Laboratories Recent Development
11.8 Fluidigm
11.8.1 Fluidigm Company Detail
11.8.2 Fluidigm Business Overview
11.8.3 Fluidigm Transcriptomics Introduction
11.8.4 Fluidigm Revenue in Transcriptomics Business (2019-2024)
11.8.5 Fluidigm Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂